These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Myocardial protection from ischemia-reperfusion injury post coronary revascularization. Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544 [TBL] [Abstract][Full Text] [Related]
84. Aldose reductase: a novel target for cardioprotective interventions. Ramasamy R Curr Drug Targets; 2003 Nov; 4(8):625-32. PubMed ID: 14577653 [TBL] [Abstract][Full Text] [Related]
85. Heme oxygenase-1: an important therapeutic target for protecting against myocardial ischemia and reperfusion injury. Hu X; Wang J; Jiang H Int J Cardiol; 2013 Jul; 167(2):587-8. PubMed ID: 23084548 [No Abstract] [Full Text] [Related]
86. The Nrf-2/ARE-HO-1 axis: An important therapeutic approach for attenuating myocardial ischemia and reperfusion injury-induced cardiac remodeling. Wang J; Hu X; Jiang H Int J Cardiol; 2015 Apr; 184():263-264. PubMed ID: 25726904 [No Abstract] [Full Text] [Related]
87. HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling. Wang J; Hu X; Jiang H Int J Cardiol; 2015; 190():126-7. PubMed ID: 25918063 [No Abstract] [Full Text] [Related]
88. Phospholipase C as a potential target for cardioprotection during oxidative stress. Tappia PS; Asemu G; Rodriguez-Leyva D Can J Physiol Pharmacol; 2010 Mar; 88(3):249-63. PubMed ID: 20393590 [TBL] [Abstract][Full Text] [Related]
89. Myocardial postconditioning: next step to cardioprotection. Rohilla A; Rohilla S; Kushnoor A Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801 [TBL] [Abstract][Full Text] [Related]